Our website will be undergoing planned maintenance starting at 5:00 PM EST on Dec. 11 and will be back in the morning of Dec. 12. During this time some features will be unavailable, like login and signup.
Our website will be undergoing planned maintenance starting at 5:00 PM EST on Dec. 11 and will be back in the morning of Dec. 12. During this time some features will be unavailable, like login and signup.

I/LA23

Assessing the Quality of Immunoassay Systems: Radioimmunoassays and Enzyme, Fluorescence, and Luminescence Immunoassays, 1st Edition

This guideline addresses components for harmonizing and assessing the quality of immunoassay systems for several commonly used dose-response indicator categories, e.g., radioisotopes, enzymes, fluorescence, luminescence, reagents, and experimental components criteria essential to characterizing an immunoassay.  

This document is available in electronic format only.

Members: $42.00 → $119.00

Nonmembers: $140.00
Log in/sign up to see price and add to cart

Publication Details

Chairholder: Dorothy J. Ball, PhD

Date of Publication: April 20, 2004

ISBN Number: 1-56238-533-X

Order Code PDF: ILA23AE

Order Code Print: print not available

Edition: First

Pages: 52

I/LA23 Additional Details

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.